DCT

2:25-cv-17250

Exeltis USA Inc v. Glenmark Pharma Ltd

General
Filed
11/06/25
Cause of ActionPatent Infringement
SectorBiotech
StatusOpen
Patent Owner
Operating Company
Nature of Suit835 ANDA
Judge
Period
PO Win Rate
--
57%